Nyrada Inc |
High $0.03 |
Low $0.03 |
Trades 20 |
Turnover $17,485 |
Volume 622,600 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (13-Nov) $133,825,608 (1,377th) |
Close (30-Jun) $0.028 |
Volume (30-Jun) 622,600 |
Shortsold (6-Nov) 27,920 (0.01%) (580th) |
|
52w High $1.44 |
52w Low $0.390 |
P/E - |
EPS -0.03 |
Corporate Presentation
NYR released this announcement to the ASX on 7 June 2022, 9:13. The announcement is marked as price sensitive, and is 30 page(s) in length and 1.82MB in size.
You can view all announcements from NYR and see how they appear on a price chart on the announcements page.
At the date of this announcement, NYR was 0.001% short sold according to ASIC data. It was ranked the 633rd most shorted stock on the ASX. It is now ranked as the 580th most shorted stock on the ASX with 0.011% of total shares short sold as of the latest reported data (06 November 2026).
| Other Recent Announcements from NYR | |
|---|---|
| Cholesterol-Lowering Program Update | 26 June 2023, 9:55 |
| Brain Injury Program Preclinical Development Update | 9 June 2023, 8:18 |
| Cholesterol-Lowering Program Preclinical Studies Completed | 26 May 2023, 8:44 |
| Corporate Presentation | 7 June 2022, 9:13 |
| Brain Injury Program Target Unveiled and Phase I Update | 6 June 2022, 8:24 |
| European Patent to be Granted for Cholesterol-Lowering Drug | 17 May 2022, 8:41 |
| Nyrada Quarterly Activities Report & Appendix 4C | 19 April 2022, 9:29 |
If you were already registered, log in here.